Abstract
This review is broadly about the phenomenon we have termed "compensatory vasodilation" 74 and is based on a presentation given at the18th International Hypoxia Symposia held in early 75
2013. This phenomenon describes the tendency of muscle blood flow to increase (or 76 decrease) depending on changes in arterial oxygen content. This is especially true during 77 exercise, when the ability to maintain oxygen consumption by changes in extraction alone is 78 somewhat limited because extraction is already high during exercise (1). The basic idea is that 79 when arterial oxygen content is reduced by hypoxia, anemia, or other reductions of functional 80 oxygen-carrying capacity (carbon monoxide for example), there is an increase in blood flow to 81 active muscles that "compensates" for the reduced arterial oxygen content and keeps oxygen 82 delivery to the active muscles relatively constant. It should also be noted that the opposite 83 occurs during hyperoxia, when there are increases in arterial oxygen content and vasodilation 84 is reduced. In this paper we briefly review our data and data from others, and discuss potential 85 mechanisms responsible for these observations. Figure 1 is a classic slide adapted from 86 Rowell and colleagues (39) showing this phenomenon. 87
88
Our interest in this topic stems from our general interest in exercise hyperemia. In this context, 89 there appears to be redundant mechanisms that contribute to exercise hyperemia including 90 various "metabolic" vasodilators (28). The idea is that vasodilating substances released by the 91 contracting muscles or other tissues in proportion to the level of contractile activity are 92 responsible for the well-known matching of blood flow and metabolism. However, identifying 93 the dominant metabolic dilating substance (if there is one) or substances has proven 94 challenging and we hoped that by altering oxygen delivery to the active muscle we might either 95 amplify or suppress one or more of the major contributors in this response. How have we studied this in humans? 98
Our basic strategy to study compensatory vasodilation in humans has used the isolated 99 forearm hand gripping model, which involves a hand grip device that allows subjects to 100 perform rhythmic forearm exercise by lifting a given weight 4-5 cm over a pulley 20 times per 101 minute. This model has a number of advantages: the small muscle mass involved means that 102 we can study vasodilator responses and give drugs in a way that does not affect the systemic 103 circulation, and it is possible to either blunt or eliminate the effects of various reflex changes in 104 autonomic outflow on the responses we seek to study. We can also use high doses of drugs 105 to block vasodilating or vasoconstricting pathways. However, the hand gripping model can 106 also be criticized because clearly the forearm is not a major locomotor muscle, and 107 cardiovascular reflexes and competition between the demands of skeletal muscle for blood 108 flow, blood pressure regulation, and blood flow to other organs are clearly present during 109 whole body exercise in real life situations. 110
111
How have we altered arterial oxygen content? 112
We have used three basic strategies to alter arterial oxygen content to the exercising muscles 113 we have studied. First is simple systemic hypoxia. For these series of experiments we used a 114 self-regulating partial rebreathe system to lower arterial oxygen saturation to around 80% while 115 clamping end-tidal CO 2 at baseline levels despite large changes in minute ventilation that 116 occur with hypoxia (3, 11-13, 45, 46) . This is accomplished by titrating the level of inspired 117 oxygen to achieve the desired arterial oxygen saturation. The amount of inspired oxygen 118 provided in the inspiratory gas was controlled by mixing nitrogen with medical air via an 119 anesthesia gas blender. 120
Another strategy we have used to alter arterial oxygen content is systemic hyperbaric 122 hyperoxia (9, 10). Traditionally, studies that have examined the impact of increased levels of 123 oxygen on blood flow during dynamic exercise have been limited to small increases in arterial 124 oxygen content (~5-10%) using a F I O2 of 100% under normobaric conditions (16, 18, 23, 44) . 125
Since our hypoxia studies have typically reduced arterial oxygen content by ∼20%, we have 126 used several atmospheres of pressure to increase arterial oxygen content by ∼20%. This has 127 permitted us to study the relationship between arterial oxygen content and blood flow "in both 128
directions." 129
130
Our final strategy to manipulate arterial oxygen content has been local hypoperfusion. In this 131
technique, we place a balloon in the brachial artery, and inflate the balloon to partially occlude 132 it (5-8). Using this technique we can acutely reduce perfusion pressure to the contracting 133 skeletal muscles of the forearm by 15-20% and forearm blood flow by 40-50%. We have not 134 used anemia or carbon monoxide in our studies. 135
136

Hypoxia is sympathoexcitatory 137
The first thing to remember about hypoxia is that it is sympathoexcitatory. This sympathetic 138 activation is due to stimulation of the carotid body chemoreceptors and there is a 50-60% rise 139 in muscle sympathetic nerve activity during systemic hypoxia (25). Normally this increase in 140 sympathetic traffic would potentially compete with or limit any local vasodilation caused by the 141 hypoxia, and at rest this is clearly the case (43, 45) . In other words, the vasodilation seen with 142 hypoxia is greater after α-adrenergic blockade of the forearm than with hypoxia alone. As 143 demonstrated in Figure 2 , there also appears to be enhanced sympathetic vasoconstrictor 144 restraint of the skeletal muscle vasculature during hypoxic exercise, as α-adrenergic blockade 145 reveals a greater vasodilation during hypoxic exercise compared with control hypoxic exercise 146 conditions (no pharmacological blockade) (45). Thus while, the ability of norepinephrine 147 released from sympathetic nerves to cause vasoconstriction in active skeletal muscle is 148 blunted during exercise, the additional sympathetic outflow evoked by systemic hypoxia can 149 still cause vasoconstriction in the active muscles. 150 151 So, our first question was to determine whether functional sympatholysis was augmented 152 during exercise under hypoxic conditions. In this study we used tyramine to cause local 153 release of norepinephrine from the sympathetic nerves in the forearm. We showed that 154 exercise clearly caused functional sympatholysis, and that functional sympatholysis (compared 155 to rest) was greater during rhythmic hand gripping at 10% and 20% of maximum voluntary 156
contraction (46). However, compared to what is observed during normoxic exercise hypoxia 157
did not augment sympatholysis. So, the classic compensatory vasodilation seen during 158 hypoxia could not be ascribed simply to augmented sympatholysis during hypoxia, clearly 159 something else, perhaps related to a "metabolic signal" from the active muscles or circulating 160 factor drives the compensatory dilator response. 161
162
Candidate dilators and compensatory vasodilation 163
Along these lines, in our hypoxia studies, we have focused on the role of β-adrenergic 164 receptors, adenosine, and nitric oxide (NO) acting alone or in combination as potential 165 candidate dilators which might contribute to compensatory vasodilation during hypoxia. During 166 mild rhythmic hand gripping (10% of maximum voluntary contraction), there is evidence that β-167 adrenergic receptor stimulation plays a role in compensatory vasodilation. However, this role 168 is not as prominent during heavier rhythmic hand gripping (20% maximum voluntary 169 contraction) (45). It is also likely that some or all of this β 2 mediated vasodilation is due to 170 stimulation of NO release from the vascular endothelium (3). 171
172
We have also studied the interactions of adenosine and NO in a complex series of 173 experiments that have blocked both pathways alone and in combination. Based on our data 174 we have concluded that NO plays a major role (≥ ~ 50%) in compensatory vasodilation and 175 that adenosine is not obligatory for this response (11, 12) . Our findings that adenosine is not 176 obligatory for the compensatory vasodilation in the forearm is in agreement with what is 177 observed in exercising human quadriceps femoris muscle during hypoxia (27) . However, it 178 should be noted that under resting conditions adenosine plays a major role in skeletal muscle 179 vasodilation in experimental animals when oxygen is reduced by acute systemic hypoxia, and 180 a substantial amount of the response is mediated by NO (19, 33, 34) . Recent evidence from 181 others has demonstrated that that the combined blockade of NO and prostaglandin pathways 182 also reduces the vasodilator response to hypoxic exercise by ~50% (17). However, single 183 inhibition trials of NO and prostaglandins were not performed in the aforementioned study and 184 therefore it is difficult to discern the relative contribution of prostaglandins and its interaction 185 with NO in the compensatory vasodilation during hypoxic exercise. As is the case for both β 2 -186 adrenergic receptor-and adenosine-mediated vasodilation, at least some of the vasodilator 187 response to prostaglandins is NO mediated (37). 188
189
There are a variety of other pathways that might contribute to compensatory vasodilation, 190 including direct effects of hypoxia on vascular smooth muscle and ATP release from red blood 191 cells as they desaturate. This latter pathway has emerged as an exciting new mechanism to 192 help match blood flow, metabolism, and oxygen delivery in contracting skeletal muscles (20) . 193 However, in some models ATP mediated dilation is due in part to stimulation of NO release 194 from the vascular endothelium (14, 35, 36) . There has also been speculation about NO 195 release from hemoglobin as a contributor to vasodilation during hypoxia (42) In this context a loss of NO mediated endothelial dilator responses with aging likely explains 226 these observations. Additionally, the ATP mechanisms mentioned above are also blunted by 227 aging (30), and unlike younger subjects there do not appear to be major sex differences in the 228 compensatory dilator responses seen in older men and women. 229
230
What about hyperoxia? 231
We have used hyperbaric hyperoxia (100% oxygen @ 2.82 atmospheres absolute) and also 232 hyperbaric normoxia (7.4% oxygen @ 2.82 atmospheres absolute) to study the effects of 233 increased oxygen content on blood flow responses to contracting muscle (9). The studies 234 conducted at 7.4% F I O2 served as an atmospheric pressure control trial and are done to control 235 for the effects of chamber pressurization on any observed responses. The fundamental 236 observations with this approach are that when arterial oxygen content is increased by an 237 estimated 25%, the blood flow responses are reduced by a similar amount. In other words, the 238 opposite directional changes are seen in comparison with hypoxia. Additionally, this reduction 239 in flow during hyperoxia is not due to a loss of functional sympatholysis and an augmented 240 sympathetic vasoconstrictor response in the active skeletal muscles (10). The extent to which 241 hyperbaric hyperoxia affects other potential vasodilator pathways such as NO, adenine 242 nucleotides, or other factors, is currently under investigation. 243
244
Hypoperfusion 245
When we use our balloon catheter system to reduce perfusion pressure in the contracting 246 forearm, we see a brief reduction in flow followed by local vasodilation which tends to return 247 flow to normal (8). Interestingly, the compensatory response appears to be "less than perfect" 248 (4-8). That is, in the majority of the studies we have conducted, flow does not return 249 completely (100% recovery) to preinflation levels. In this context, it is interesting to note that adenosine does not appear to be an important 265 contributor to responses seen during systemic hypoxia in humans (12, 27) but is an important 266 contributor seen during hypoperfusion. We should also note that prostaglandins do not appear 267 to play a major role during the local responses to hypoperfusion (7). Lastly, similar to systemic 268 hypoxia, α-adrenergic mediated vasoconstriction limits the amount of compensatory 269 vasodilation during exercise with hypoperfusion (4). Along these lines, α-adrenergic blockade 270 via phentolamine enhances the recovery of flow and vasodilation in hypoperfused contracting 271
muscle. 272 273
Summary and future directions 274
Blood flow to contracting skeletal muscles has a remarkable ability to adapt to changes in 275 arterial oxygen content. Our studies have shown this both with systemic hypoxia and 276 hyperoxia along with skeletal muscle hypoperfusion. Others have shown similar responses 277 during anemia and systemic carbon monoxide administration (24, 38) . 278
279
During both hypoxia and hyperoxia, alterations in the way that the sympathetic nervous system 280 interacts with local vasodilator mechanisms (functional sympatholysis) probably do not play a 281 major role in modulating these responses. During systemic hypoxia there can be release of 282 epinephrine and this epinephrine release and increase in circulating epinephrine could in fact 283 contribute to the compensatory vasodilator response. 284
285
At this time, NO appears to be a major contributor to the compensatory dilator responses seen 286 during both hypoxia and hypoperfusion, but it is unclear whether this NO release is due to 287 direct stimulation of the vascular endothelium, NO release from the active skeletal muscles, 288 potentiation of a non-NOS NO pathway, release of some mediator (ATP?) that then evokes 289 NO release from the vascular endothelium, or perhaps a direct effect of hypoxia on vascular 290 smooth muscle that then stimulates flow-induced NO release. The contribution and 291 interactions between potential vasodilator substances are illustrated in Figure 4 . These 292 responses appear to be augmented in healthy young women. Our studies in healthy older 293 humans demonstrate that compensatory vasodilation during hypoxic exercise is blunted with 294 aging in both sexes and likely due a loss of NO mediated endothelial vasodilator function. In 295 this context, there may be further reductions in compensatory vasodilator responses with 296 pathophysiological conditions such as hypertension and diabetes. If these responses also 297 occurred in other vascular beds then the consequences of tissue hypoxia or hypoperfusion 298 might be even more problematic in diseases states. As always for both exercise hyperemia 299 and NO, it could be "some of the above" or "all of the above," when thinking about vasodilator 300 mechanisms and exercise. The fact that differences in dilator mechanisms are seen when 301 different approaches are used to alter oxygen delivery to contracting muscles is not surprising 302 to us given the highly redundant regulatory control mechanisms associated for exercise 303 During hypoxic exercise NO is the final common pathway for the compensatory dilator 462
